91AV

Introduction

Tremendous progress is being made in cancer diagnostics, and the proliferation of novel tests is truly historic. Gene expression panels from microarray data and next-generation sequencing are being used for the early detection and prognosis of cancer. Tumor aggressiveness and therapy selection are being determined by these technologies, and the number of companies competing in this space is growing rapidly. Plan to attend to learn key factors in implementation and adoption, and gather intelligence about the types of assays from experts in the field.

Useful links

Venue

Ritz-Carlton Hotel

Ritz-Carlton Hotel, Washington, DC, United States

Organised by

Cambridge Healthtech Institute

Contact information

Mr CHI Representative
United States of America
+ 781-972-5400
Contact us by email

---